392 related articles for article (PubMed ID: 33976213)
21. A Practical Guide to Integrating Multimodal Machine Learning and Metabolic Modeling.
Vijayakumar S; Magazzù G; Moon P; Occhipinti A; Angione C
Methods Mol Biol; 2022; 2399():87-122. PubMed ID: 35604554
[TBL] [Abstract][Full Text] [Related]
22. Min-redundancy and max-relevance multi-view feature selection for predicting ovarian cancer survival using multi-omics data.
El-Manzalawy Y; Hsieh TY; Shivakumar M; Kim D; Honavar V
BMC Med Genomics; 2018 Sep; 11(Suppl 3):71. PubMed ID: 30255801
[TBL] [Abstract][Full Text] [Related]
23. A multi-omics machine learning framework in predicting the survival of colorectal cancer patients.
Yang M; Yang H; Ji L; Hu X; Tian G; Wang B; Yang J
Comput Biol Med; 2022 Jul; 146():105516. PubMed ID: 35468406
[TBL] [Abstract][Full Text] [Related]
24. Interpretable meta-learning of multi-omics data for survival analysis and pathway enrichment.
Cho HJ; Shu M; Bekiranov S; Zang C; Zhang A
Bioinformatics; 2023 Apr; 39(4):. PubMed ID: 36864611
[TBL] [Abstract][Full Text] [Related]
25. Large-scale benchmark study of survival prediction methods using multi-omics data.
Herrmann M; Probst P; Hornung R; Jurinovic V; Boulesteix AL
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32823283
[TBL] [Abstract][Full Text] [Related]
26. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas.
Way GP; Sanchez-Vega F; La K; Armenia J; Chatila WK; Luna A; Sander C; Cherniack AD; Mina M; Ciriello G; Schultz N; ; Sanchez Y; Greene CS
Cell Rep; 2018 Apr; 23(1):172-180.e3. PubMed ID: 29617658
[TBL] [Abstract][Full Text] [Related]
27. Machine Learning Identifies Robust Matrisome Markers and Regulatory Mechanisms in Cancer.
Kääriäinen A; Pesola V; Dittmann A; Kontio J; Koivunen J; Pihlajaniemi T; Izzi V
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33266472
[TBL] [Abstract][Full Text] [Related]
28. Predicting Deep Learning Based Multi-Omics Parallel Integration Survival Subtypes in Lung Cancer Using Reverse Phase Protein Array Data.
Takahashi S; Asada K; Takasawa K; Shimoyama R; Sakai A; Bolatkan A; Shinkai N; Kobayashi K; Komatsu M; Kaneko S; Sese J; Hamamoto R
Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33086649
[TBL] [Abstract][Full Text] [Related]
29. Using a machine learning approach to identify key prognostic molecules for esophageal squamous cell carcinoma.
Li MX; Sun XM; Cheng WG; Ruan HJ; Liu K; Chen P; Xu HJ; Gao SG; Feng XS; Qi YJ
BMC Cancer; 2021 Aug; 21(1):906. PubMed ID: 34372798
[TBL] [Abstract][Full Text] [Related]
30. LinkedOmics: analyzing multi-omics data within and across 32 cancer types.
Vasaikar SV; Straub P; Wang J; Zhang B
Nucleic Acids Res; 2018 Jan; 46(D1):D956-D963. PubMed ID: 29136207
[TBL] [Abstract][Full Text] [Related]
31. DROEG: a method for cancer drug response prediction based on omics and essential genes integration.
Wu P; Sun R; Fahira A; Chen Y; Jiangzhou H; Wang K; Yang Q; Dai Y; Pan D; Shi Y; Wang Z
Brief Bioinform; 2023 Mar; 24(2):. PubMed ID: 36715269
[TBL] [Abstract][Full Text] [Related]
32. Knowledge Generation with Rule Induction in Cancer Omics.
Scala G; Federico A; Fortino V; Greco D; Majello B
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861438
[TBL] [Abstract][Full Text] [Related]
33. Gene-centric multi-omics integration with convolutional encoders for cancer drug response prediction.
Lee M; Kim PJ; Joe H; Kim HG
Comput Biol Med; 2022 Dec; 151(Pt A):106192. PubMed ID: 36327883
[TBL] [Abstract][Full Text] [Related]
34. Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients.
Ankney JA; Xie L; Wrobel JA; Wang L; Chen X
BMC Med Genomics; 2019 May; 12(1):78. PubMed ID: 31146747
[TBL] [Abstract][Full Text] [Related]
35. A critical review of machine-learning for "multi-omics" marine metabolite datasets.
Manochkumar J; Cherukuri AK; Kumar RS; Almansour AI; Ramamoorthy S; Efferth T
Comput Biol Med; 2023 Oct; 165():107425. PubMed ID: 37696182
[TBL] [Abstract][Full Text] [Related]
36. Development of a 12-biomarkers-based prognostic model for pancreatic cancer using multi-omics integrated analysis.
Jia Y; Shen M; Zhou Y; Liu H
Acta Biochim Pol; 2020 Dec; 67(4):501-508. PubMed ID: 33253517
[TBL] [Abstract][Full Text] [Related]
37. Integrating multi-omics data by learning modality invariant representations for improved prediction of overall survival of cancer.
Tong L; Wu H; Wang MD
Methods; 2021 May; 189():74-85. PubMed ID: 32763377
[TBL] [Abstract][Full Text] [Related]
38. High-dose Ionizing Radiation Regulates Gene Expression Changes in the MCF7 Breast Cancer Cell Line.
Bravatà V; Minafra L; Russo G; Forte GI; Cammarata FP; Ripamonti M; Casarino C; Augello G; Costantini F; Barbieri G; Messa C; Gilardi MC
Anticancer Res; 2015 May; 35(5):2577-91. PubMed ID: 25964533
[TBL] [Abstract][Full Text] [Related]
39. Development and Validation of a Novel Radiosensitivity Signature in Human Breast Cancer.
Speers C; Zhao S; Liu M; Bartelink H; Pierce LJ; Feng FY
Clin Cancer Res; 2015 Aug; 21(16):3667-77. PubMed ID: 25904749
[TBL] [Abstract][Full Text] [Related]
40. EMLI-ICC: an ensemble machine learning-based integration algorithm for metastasis prediction and risk stratification in intrahepatic cholangiocarcinoma.
Ruan J; Xu S; Chen R; Qu W; Li Q; Ye C; Wu W; Jiang Q; Yan F; Shen E; Chu Q; Jia Y; Zhang X; Fu W; Chen J; Timko MP; Zhao P; Fan L; Shen Y
Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36259363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
